Literature DB >> 14673119

Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope.

Marika C Kullberg1, John F Andersen, Peter L Gorelick, Patricia Caspar, Sebastian Suerbaum, James G Fox, Allen W Cheever, Dragana Jankovic, Alan Sher.   

Abstract

It is now well established that the intestinal flora plays an important role in the pathogenesis of inflammatory bowel disease (IBD). However, whether bacteria serve as the sole target of the immune response in this process or whether they act indirectly by triggering an anti-self response is still unclear. We have previously shown that specific pathogen-free IL-10-deficient (IL-10 KO) mice develop a T helper (Th1)-cytokine associated colitis after experimental infection with Helicobacter hepaticus. We here show that H. hepaticus Ag (SHelAg)-specific CD4+ Th1 clones transfer disease to H. hepaticus-infected T cell-deficient RAG KO hosts. Importantly, uninfected recipients of the SHelAg-specific clones did not develop intestinal inflammation, and a control Schistosoma mansoni-specific Th1 clone did not induce colitis upon transfer to infected RAG KO mice. The disease-inducing T cell clones recognized antigen(s) (Ag) specifically expressed by certain Helicobacter species as they responded when stimulated in vitro with H. hepaticus and Helicobacter typhlonius Ag, but not when cultured with Ag preparations from Helicobacter pylori, various non-helicobacter bacteria, or with cecal bacterial lysate from uninfected mice. Characterization of the Ag specificity of one of the clones showed that it reacts uniquely with a 15-mer peptide epitope on the flagellar hook protein (FlgE) of H. hepaticus presented by I-Ab. Together, our results demonstrate that colitis can be induced by clonal T cell populations that are highly specific for target Ag on intestinal bacteria, suggesting that an aberrant T cell response directed against gut flora is sufficient to trigger IBD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673119      PMCID: PMC307653          DOI: 10.1073/pnas.2534546100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

Authors:  M Campieri; P Gionchetti
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

Review 2.  T cells in inflammatory bowel disease: protective and pathogenic roles.

Authors:  F Powrie
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

3.  Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni.

Authors:  D Jankovic; L Aslund; I P Oswald; P Caspar; C Champion; E Pearce; J E Coligan; M Strand; A Sher; S L James
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

4.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

5.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

Authors:  L Dianda; A M Hanby; N A Wright; A Sebesteny; A C Hayday; M J Owen
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

Review 6.  Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.

Authors:  R B Sartor
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

7.  Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.

Authors:  Z Xiang; S Censini; P F Bayeli; J L Telford; N Figura; R Rappuoli; A Covacci
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Identification of surface-exposed outer membrane antigens of Helicobacter pylori.

Authors:  P Doig; T J Trust
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

10.  CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.

Authors:  Y Cong; S L Brandwein; R P McCabe; A Lazenby; E H Birkenmeier; J P Sundberg; C O Elson
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

View more
  40 in total

1.  Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease.

Authors:  Mark J Asquith; Olivier Boulard; Fiona Powrie; Kevin J Maloy
Journal:  Gastroenterology       Date:  2010-04-28       Impact factor: 22.682

Review 2.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 3.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

Review 4.  Host-bacterial symbiosis in health and disease.

Authors:  Janet Chow; S Melanie Lee; Yue Shen; Arya Khosravi; Sarkis K Mazmanian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis.

Authors:  Takayuki Kajiura; Tomoko Takeda; Shinji Sakata; Mitsuo Sakamoto; Masaki Hashimoto; Hideki Suzuki; Manabu Suzuki; Yoshimi Benno
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

Review 6.  The Colon as a Major Site of Immunoregulation by CD4+ T Cell Subsets in the Steady State.

Authors:  Alan Sher; Brian L Kelsall
Journal:  J Immunol       Date:  2019-10-01       Impact factor: 5.422

7.  CD4+ T-cell responses and distribution at the colonic mucosa during Brachyspira hyodysenteriae-induced colitis in pigs.

Authors:  Raquel Hontecillas; Josep Bassaganya-Riera; Jennifer Wilson; David L Hutto; Michael J Wannemuehler
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

8.  Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.

Authors:  Sara M Dann; Christine Le; Barun K Choudhury; Houpu Liu; Omar Saldarriaga; Elaine M Hanson; Yingzi Cong; Lars Eckmann
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

9.  Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.

Authors:  Adam E Snook; Michael S Magee; Stephanie Schulz; Scott A Waldman
Journal:  Eur J Immunol       Date:  2014-05-21       Impact factor: 5.532

10.  Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice.

Authors:  Maciej Chichlowski; Julie M Sharp; Deborah A Vanderford; Matthew H Myles; Laura P Hale
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.